CDIO
Cardio Diagnostics Holdings Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website cardiodiagnosticsinc.com
- Employees(FY) 7
- ISIN US14159C1036
Performance
+10.6%
1W
-19.8%
1M
-59.85%
3M
-77.55%
6M
-77.91%
YTD
-56.0%
1Y
Profile
Cardio Diagnostics Holdings, Inc., an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago, Illinois.
Technical Analysis of CDIO 2024-05-31
Overview:
In analyzing the technical indicators for CDIO stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for informe...
Recent News & Updates
- 2024-06-26 20:31
- 2024-06-24 20:31
- 2024-06-21 00:52
- 2024-06-09 20:31
- 2024-05-20 20:31
- 2024-05-12 20:31
- 2024-05-06 20:45
- 2024-04-30 20:30
- 2024-04-28 20:31
- 2024-04-23 20:30
- 2024-04-11 20:45
- 2024-04-08 20:31
- 2024-04-03 20:31
- 2024-03-13 20:31
- 2024-03-04 19:31
- 2024-02-14 19:46
- 2024-02-06 19:31
- 2024-02-04 19:31
- 2024-01-23 19:31
- 2024-01-07 19:31
- 2024-01-03 22:36
- 2024-01-03 19:31
- 2024-01-02 19:31
- 2024-01-01 19:31
- 2023-12-20 20:21
- 2023-12-05 19:31
- 2023-12-04 04:38
- 2023-12-03 19:31
- 2023-11-27 19:31
- 2023-11-19 20:00
Page 1 of 3
previousnext